Artiva Biotherapeutics, Inc. Common Stock Financial Flexibility Index
Artiva Biotherapeutics, Inc. Common Stock financial flexibility index. Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Financial Flexibility Index of -0.95x as of September 2025. Free cash flow of $-18.60 Million (operating CF $-19.20 Million minus capex $600.00K) represents -1% of total liabilities ($19.64 Million). Check ARTV asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Artiva Biotherapeutics, Inc. Common Stock (2020–2024)
Financial flexibility index of Artiva Biotherapeutics, Inc. Common Stock from 2020 to 2024. Historical Financial Flexibility Index trend for Artiva Biotherapeutics, Inc. Common Stock across 5 annual periods. Explore Artiva Biotherapeutics, Inc. Common Stoc (ARTV) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Artiva Biotherapeutics, Inc. Common Stock Financial Flexibility Index by Year (2020–2024)
Artiva Biotherapeutics, Inc. Common Stock financial flexibility index by year from 2020 to 2024. Year-by-year free cash flow to debt coverage for Artiva Biotherapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see ARTV cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.37x | $-54.39 Million | $-55.03 Million | $22.94 Million | ▼ -1333.8% |
| 2023 | -0.17x | $-44.17 Million | $-47.43 Million | $267.13 Million | ▼ -1.7% |
| 2022 | -0.16x | $-44.53 Million | $-50.83 Million | $273.75 Million | ▼ -210.0% |
| 2021 | -0.05x | $-13.58 Million | $-15.30 Million | $258.78 Million | ▲ +79.9% |
| 2020 | -0.26x | $-13.26 Million | $-13.54 Million | $50.80 Million | — |